Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
- PMID: 11440935
- PMCID: PMC34324
- DOI: 10.1136/bmj.323.7303.13
Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
Abstract
Objective: To establish whether cannabis is an effective and safe treatment option in the management of pain.
Design: Systematic review of randomised controlled trials.
Data sources: Electronic databases Medline, Embase, Oxford Pain Database, and Cochrane Library; references from identified papers; hand searches.
Study selection: Trials of cannabis given by any route of administration (experimental intervention) with any analgesic or placebo (control intervention) in patients with acute, chronic non-malignant, or cancer pain. Outcomes examined were pain intensity scores, pain relief scores, and adverse effects. Validity of trials was assessed independently with the Oxford score.
Data extraction: Independent data extraction; discrepancies resolved by consensus.
Data synthesis: 20 randomised controlled trials were identified, 11 of which were excluded. Of the 9 included trials (222 patients), 5 trials related to cancer pain, 2 to chronic non-malignant pain, and 2 to acute postoperative pain. No randomised controlled trials evaluated cannabis; all tested active substances were cannabinoids. Oral delta-9-tetrahydrocannabinol (THC) 5-20 mg, an oral synthetic nitrogen analogue of THC 1 mg, and intramuscular levonantradol 1.5-3 mg were about as effective as codeine 50-120 mg, and oral benzopyranoperidine 2-4 mg was less effective than codeine 60-120 mg and no better than placebo. Adverse effects, most often psychotropic, were common.
Conclusion: Cannabinoids are no more effective than codeine in controlling pain and have depressant effects on the central nervous system that limit their use. Their widespread introduction into clinical practice for pain management is therefore undesirable. In acute postoperative pain they should not be used. Before cannabinoids can be considered for treating spasticity and neuropathic pain, further valid randomised controlled studies are needed.
Figures
Comment in
-
Cannabinoids for pain and nausea.BMJ. 2001 Jul 7;323(7303):2-3. doi: 10.1136/bmj.323.7303.2. BMJ. 2001. PMID: 11440921 Free PMC article. No abstract available.
-
Cannabinoids in pain management. Study was bound to conclude that cannabinoids had limited efficacy.BMJ. 2001 Nov 24;323(7323):1249-50; author reply 1250-1. BMJ. 2001. PMID: 11719420 Free PMC article. No abstract available.
-
Cannabinoids in pain management. Cannabinoid receptor agonists will soon find their place in modern medicine.BMJ. 2001 Nov 24;323(7323):1250-1. BMJ. 2001. PMID: 11758520 No abstract available.
-
Cannabinoids in pain management. Few well controlled trials of cannabis exist for systemic review.BMJ. 2001 Nov 24;323(7323):1250; author reply 1250-1. BMJ. 2001. PMID: 11758521 No abstract available.
-
Cannabinoids in pain management. Spasticity is not the same as pain.BMJ. 2001 Nov 24;323(7323):1250; author reply 1250-1. BMJ. 2001. PMID: 11758522 No abstract available.
-
Review: cannabinoids and codeine have similar effects on pain relief, but cannabinoids commonly cause adverse psychotropic effects.ACP J Club. 2002 Jan-Feb;136(1):18. ACP J Club. 2002. PMID: 11829559 No abstract available.
Similar articles
-
Cannabis-based medicines for chronic neuropathic pain in adults.Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2. Cochrane Database Syst Rev. 2018. PMID: 29513392 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.Cochrane Database Syst Rev. 2022 May 5;5(5):CD013444. doi: 10.1002/14651858.CD013444.pub2. Cochrane Database Syst Rev. 2022. PMID: 35510826 Free PMC article.
-
Herbal and dietary therapies for primary and secondary dysmenorrhoea.Cochrane Database Syst Rev. 2001;(3):CD002124. doi: 10.1002/14651858.CD002124. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2016 Mar 22;3:CD002124. doi: 10.1002/14651858.CD002124.pub2. PMID: 11687013 Updated.
Cited by
-
[Cannabinoids--signal transduction and mode of action].Schmerz. 2005 Nov;19(6):528-34. doi: 10.1007/s00482-004-0349-8. Schmerz. 2005. PMID: 15549420 Review. German.
-
Endocannabinoid-related compounds in gastrointestinal diseases.J Cell Mol Med. 2018 Feb;22(2):706-715. doi: 10.1111/jcmm.13359. Epub 2017 Oct 9. J Cell Mol Med. 2018. PMID: 28990365 Free PMC article. Review.
-
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.Br J Clin Pharmacol. 2011 Nov;72(5):735-44. doi: 10.1111/j.1365-2125.2011.03970.x. Br J Clin Pharmacol. 2011. PMID: 21426373 Free PMC article.
-
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.Mol Neurobiol. 2012 Oct;46(2):374-92. doi: 10.1007/s12035-012-8299-0. Epub 2012 Jul 17. Mol Neurobiol. 2012. PMID: 22801993 Review.
-
Is there a role for marijuana in medical practice?Can Fam Physician. 2006 Dec;52(12):1531-3, 1535-7. Can Fam Physician. 2006. PMID: 17279226 Free PMC article. No abstract available.
References
-
- Martin WJ, Loo CM, Basbaum AI. Cannabinoids are anti-allodynic in rats with persistent inflammation. Pain. 1999;82(2):199–205. - PubMed
-
- Martin WJ. Basic mechanisms of cannabinoid-induced analgesia. IASP Newsletter 1999;summer:3-6.
-
- Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth. 1999;83:637–649. - PubMed
-
- BM Association. Therapeutic uses of cannabis. Amsterdam: Harwood Academic; 1997.
-
- Meek C. Doctors want cannabis prescriptions allowed. BMA News Review 1994;February:1-19.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical